Home LiteratureArticle Details
PMID: 4241814 Published · ppublish English Journal Article

Studies on a complex mechanism for the activation of plasminogen by kaolin and by chloroform: the participation of Hageman factor and additional cofactors.

The Journal of clinical investigation ·Vol. 48 ·No. 10 ·1969-10-00 ·Pages 1786-801

Ogston D, Ogston CM, Ratnoff OD, Forbes CD

Abstract

As demonstrated by others, fibrinolytic activity was generated in diluted, acidified normal plasma exposed to kaolin, a process requiring Hageman factor (Factor XII). Generation was impaired by adsorbing plasma with glass or similar agents under conditions which did not deplete its content of Hageman factor or plasminogen. The defect could be repaired by addition of a noneuglobulin fraction of plasma or an agent or agents eluted from diatomaceous earth which had been exposed to normal plasma. The restorative agent, tentatively called Hageman factor-cofactor, was partially purified by chromatography and had an apparent molecular weight of approximately 165,000. It could be distinguished from plasma thromboplastin antecedent (Factor XI) and plasma kallikrein, other substrates of Hageman factor, and from the streptokinase-activated pro-activator of plasminogen. Evidence is presented that an additional component may be needed for the generation of fibrinolytic activity in mixtures containing Hageman factor, HF-cofactor, and plasminogen.The long-recognized generation of plasmin activity in chloroform-treated euglobulin fractions of plasma was found to be dependent upon the presence of Hageman factor. Whether chloroform activation of plasminogen requires Hageman factor-cofactor was not determined, but glass-adsorbed plasma, containing Hageman factor and plasminogen, did not generate appreciable fibrinolytic or caseinolytic activity. These studies emphasize the complex nature of the mechanisms which lead to the generation of plasmin in human plasma.

MeSH Terms
Blood Coagulation Factors Chloroform Chromatography Factor XII Fibrinolysin/biosynthesis Fibrinolysis Fibrinolytic Agents Humans Kaolin Molecular Weight Plasminogen
Chemicals
Blood Coagulation Factors Fibrinolytic Agents Kaolin Chloroform Factor XII Plasminogen Fibrinolysin
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Ogston D
Ogston C M
Ratnoff O D
Forbes C D
References (41)
41 references, click to expand
  1. Selective inactivation of the plasminogen contaminant in thrombin.
    Nature. 1960 Nov 12;188:582-3 PMID: 13766973
  2. A plasminogen activator in spontaneously active human blood.
    Proc Soc Exp Biol Med. 1953 Feb;82(2):291-5 PMID: 13037876
  3. The purification of activated Hageman factor (activated factor XII).
    Biochemistry. 1962 Nov;1:967-75 PMID: 13973274
  4. The inhibition of plasmin, plasma kallikrein, plasma permeability factor, and the C'1r subcomponent of the first component of complement by serum C'1 esterase inhibitor.
    J Exp Med. 1969 Feb 1;129(2):315-31 PMID: 4178758
  5. Studies on the thrombolytic activity of human plasma.
    J Clin Invest. 1960 Feb;39:426-34 PMID: 14442118
  6. Abolition of the permeability-enhancing properties of Hageman factor by specific antiserum.
    J Lab Clin Med. 1967 Sep;70(3):365-71 PMID: 4166883
  7. Induction of fibrinolysis by venous obstruction.
    Angiology. 1960 Oct;11:367-70 PMID: 13693901
  8. Immunologic demonstration of a deficiency of Hageman factor-like material in Hageman trait.
    J Lab Clin Med. 1967 May;69(5):819-32 PMID: 4960805
  9. ACTIVATION OF HAGEMAN FACTOR BY SOLUTIONS OF ELLAGIC ACID.
    J Lab Clin Med. 1964 Mar;63:359-77 PMID: 14165678
  10. HAGEMAN FACTOR IN THE FIBRINOLYTIC SYSTEM.
    Lancet. 1965 Feb 20;1(7382):437-8 PMID: 14238112
  11. [FIBRINOLYTIC PROPERTIES OF THE CONTACT FACTOR].
    Rev Esp Fisiol. 1964 Jun;20:43-51 PMID: 14185256
  12. Partial purification and properties of a proteolytic enzyme of human serum.
    J Biol Chem. 1949 Nov;181(1):431-48 PMID: 15390425
  13. Activation of endogenous plasma proteolytic enzymes with the consequent production of pharmacologically active polypeptides.
    Nature. 1962 Sep 22;195:1206-7 PMID: 14467938
  14. PURIFICATION OF ACTIVATED BOVINE HAGEMAN FACTOR.
    Thromb Diath Haemorrh. 1963 Jul 31;35:546-56 PMID: 14077570
  15. The histological localisation of fibrinolysin activator.
    J Pathol Bacteriol. 1959 Jul;78:281-3 PMID: 13838613
  16. Activation of Hageman factor by L-homocystine.
    Science. 1968 Nov 29;162(3857):1007-9 PMID: 5748939
  17. Effect of physical exercise on blood clotting and fibrinolysis.
    J Appl Physiol. 1963 Mar;18:337-44 PMID: 13956119
  18. The role of HF (factor XII) in the pathogenesis of the thrombolytic state induced by venous occlusion.
    Thromb Diath Haemorrh. 1966 Jul 31;16(1):207-17 PMID: 4229626
  19. Studies on the action of Hageman factor: evidence that activated Hageman factor in turn activates plasma thromboplastin antecedent.
    J Clin Invest. 1961 May;40:803-19 PMID: 13739760
  20. Kinin formation and fibrinolysis in human plasma.
    J Physiol. 1963 May;166(3):514-29 PMID: 16992150
  21. The activation of human plasminogen. I. Spontaneous activation in glycerol.
    J Biol Chem. 1958 Jul;233(1):81-5 PMID: 13563445
  22. Studies on the purification of antihemophilic factor (factor 8. I. Precipitation of antihemophilic factor by concanavalin A.
    J Clin Invest. 1969 Feb;48(2):351-8 PMID: 5812636
  23. Occurrence of fibrinolytic activity following administration of incotinic acid.
    Proc Soc Exp Biol Med. 1958 Aug-Sep;98(4):755-7 PMID: 13591332
  24. An inherited qualitative abnormality in plasma fibrinogen: fibrinogen Cleveland.
    J Lab Clin Med. 1968 Sep;72(3):455-72 PMID: 5674077
  25. A familial hemorrhagic trait associated with a deficiency of a clot-promoting fraction of plasma.
    J Clin Invest. 1955 Apr;34(4):602-13 PMID: 14367514
  26. THE INDUCTION OF PERMEABILITY-INCREASING ACTIVITY IN HUMAN PLASMA BY ACTIVATED HAGEMAN FACTOR.
    Br J Exp Pathol. 1964 Jun;45:328-45 PMID: 14173175
  27. Investigation of serum trypsin and related substances. I. The quantitative demonstration of trypsinlike activity in human blood serum by a micromethod.
    Arch Biochem Biophys. 1962 Apr;97:159-63 PMID: 13912641
  28. HAGEMAN FACTOR AND IN VIVO ACTIVATION OF FIBRINOLYSIS.
    J Lab Clin Med. 1964 Nov;64:778-86 PMID: 14226397
  29. Formation and properties of the activator of plasminogen and of human and bovine plasmin.
    Biochem J. 1955 Nov;61(3):424-34 PMID: 13269378
  30. Studies on a proteolytic enzyme system of the blood. Activation of profibrinolysin by serum fibrinolysokinase.
    Proc Soc Exp Biol Med. 1951 Oct;78(1):184-8 PMID: 14891960
  31. Protein measurement with the Folin phenol reagent.
    J Biol Chem. 1951 Nov;193(1):265-75 PMID: 14907713
  32. Actie Hageman factor: a plasma lysokinase of the human fibrinolytic system.
    J Clin Invest. 1962 Jun;41:1277-87 PMID: 14450472
  33. The mechanism of clot dissolution by plasmin.
    J Clin Invest. 1959 Jul;38(7):1086-95 PMID: 13664784
  34. Plasminoplastin generation test of normal, HF-, PTA-, X-, PTC-, and AHF- platelet-poor plasmas: evidence that only HF- plasma has an abnormal fibrinolytic activity.
    Nature. 1965 Sep 25;207(5004):1404-5 PMID: 5886054
  35. [Role of the contact factor (Hageman factor) in fibrinolysis].
    Thromb Diath Haemorrh. 1959 Sep 1;3:593-603 PMID: 14427142
  36. The blood-clotting mechanism during normal parturition.
    J Lab Clin Med. 1954 Sep;44(3):408-15 PMID: 13201849
  37. Fibrinolysins of human plasma; a comparison of fibrinolytic plasma from normal subjects and from cadaver blood with plasmin prepared by activation with chloroform.
    Biochem J. 1953 Oct;55(3):497-506 PMID: 13105661
  38. EFFECT OF HEXADIMETHRINE BROMIDE ON PLASMA KININ FORMATION, HYDROLYSIS OF P-TOSYL-L-ARGININE METHYL ESTER AND FIBRINOLYSIS.
    Br J Pharmacol Chemother. 1964 Feb;22:87-103 PMID: 14126061
  39. Changes in fibrinolytic activity produced by physical activity.
    Lancet. 1961 Sep 30;2(7205):730-3 PMID: 14481317
  40. Proactivator function of human plasmin as shown by lysine esterase assay.
    J Biol Chem. 1961 Oct;236:2807-12 PMID: 14456992
  41. Studies on the prekallikrein (kallikreinogen)--kallikrein enzyme system of human plasma. I. Isolation and purification of plasma kallikreins.
    J Clin Invest. 1969 Jan;48(1):11-22 PMID: 4974623
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
1969-10-00
Pages
1786-801
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC322415
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]